BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10365839)

  • 1. Correlation between DNA content and p53 deletion in colorectal cancer.
    Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
    Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
    Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
    Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
    Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
    De Angelis PM; Clausen OP; Schjølberg A; Stokke T
    Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
    McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
    J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma.
    D'Agnano I; Cosimelli M; La Pera A; Cavaliere F; Mannella E; Giannarelli D; Cavaliere R; Zupi G
    Anticancer Res; 1993; 13(3):699-703. PubMed ID: 8317899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
    Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
    Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
    Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
    Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
    Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
    Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
    Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
    Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.
    Carder P; Wyllie AH; Purdie CA; Morris RG; White S; Piris J; Bird CC
    Oncogene; 1993 May; 8(5):1397-401. PubMed ID: 8479757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
    Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer.
    Purdie CA; Piris J; Bird CC; Wyllie AH
    J Pathol; 1995 Mar; 175(3):297-302. PubMed ID: 7745498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.